Minerva Neurosciences | NERV - Кредиторская задолженность





Кредиторская задолженность Изменить Дата
Acadia Pharmaceuticals USD 44.57M 32.32M 2026-06
Adma Biologics USD 31.72M 11.2M 2026-06
ALKERMES USD 142.86M 40.5M 2026-06
Alterity Therapeutics Limited AUD 1.07M 203.72K 2025-12
AstraZeneca USD 22.89B 388M 2026-06
BioCryst Pharmaceuticals USD 11.46M 501K 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Cipla INR 32.3B 1.95B 2026-03
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 2.53M 173K 2026-03
CSL USD 3.17B 290M 2025-12
Eli Lilly USD 6.11B 1.08B 2026-06
GlaxoSmithKline GBP 14.34B 7M 2026-06
Grifols EUR 987.75M 47.87M 2025-12
Halozyme Therapeutics USD 23.61M 9.51M 2026-06
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
J&J USD 9.22B 1.24B 2026-06
Merck USD 3.83B 36M 2026-06
Minerva Neurosciences USD 640K 305K 2025-12
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Novartis USD 4.26B 64M 2026-06
Novavax USD 22.94M 6.84M 2026-06
Pfizer USD 4.58B 75M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Sanofi EUR 23.6B 888M 2026-06
Takeda JPY 446.78B 44.56B 2026-06
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12